Monroe Capital (MRCC) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
13 Mar, 2026Opening remarks and agenda
The meeting was called to order by the CFO and CIO, who also served as chairman, with board members and the corporate secretary present.
Notice of the meeting was confirmed as properly given to all shareholders of record as of January 15, 2026.
The agenda included two main items: approval of the asset sale proposal and approval of the merger proposal.
Specific resolutions to be voted on
Proposal one: approval of the asset sale, recommended by the board and independent directors.
Proposal two: approval of the merger, also recommended by the board and independent directors.
Corporate governance
Quorum was established with 63.13% of voting power present, meeting requirements for valid proceedings.
An independent inspector of election was appointed and sworn in to oversee the voting process.
Latest events from Monroe Capital
- Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCC
Proxy Filing11 Mar 2026 - Supplement updates proxy materials for a proposed transaction, referencing recent filings.MRCC
Proxy Filing6 Mar 2026 - Net investment income and NAV declined year-over-year, with merger expected to unlock value.MRCC
Q4 20255 Mar 2026 - Director election and share sale authorization approved; no shareholder questions raised.MRCC
AGM 20243 Feb 2026 - Adjusted NII rose to $0.31/share, covering the dividend as NAV and leverage declined.MRCC
Q2 20242 Feb 2026 - Shareholders to vote on merger and asset sale, with NAV-based share exchange and fee waiver.MRCC
Proxy Filing20 Jan 2026 - Dividend coverage strong, NAV dipped, non-accruals up, Wendel partnership adds $1B capital.MRCC
Q3 202414 Jan 2026 - Q4 income covered dividends; NAV dipped, but 2025 outlook targets growth and risk discipline.MRCC
Q4 202416 Dec 2025 - Shareholders to vote on unchanged advisory agreement after Wendel acquires 75% of Monroe.MRCC
Proxy Filing2 Dec 2025